Validation of HIV-infected cohort identification using automated clinical data in the Department of Veterans Affairs.


Journal

HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392

Informations de publication

Date de publication:
09 2019
Historique:
accepted: 18 04 2019
pubmed: 28 5 2019
medline: 29 5 2020
entrez: 28 5 2019
Statut: ppublish

Résumé

The US Department of Veterans Affairs (VA) is the largest integrated health care provider for HIV-infected patients in the USA. VA data for HIV-specific clinical and quality improvement research are an important resource. We sought to determine the accuracy of using the VA Corporate Data Warehouse (CDW), a fully automated medical records database for all VA users nationally, to identify HIV-infected patients compared with a gold-standard VA HIV Clinical Case Registry (CCR). We assessed the test performance characteristics of each of our CDW criteria-based algorithms (presence of one, two or all of the following: diagnostic codes for HIV, positive HIV laboratory tests, and prescription for HIV medication) by calculating their sensitivity (proportion of HIV-positive patients in the CCR accurately detected as HIV-positive by the CDW algorithm) and positive predictive value (PPV; the proportion of patients identified by the CDW algorithm who were classified as HIV-positive from the CCR). We found that using a CDW algorithm requiring two of three HIV diagnostic criteria yielded the highest sensitivity (95.2%) with very little trade-off in PPV (93.5%). A two diagnostic criteria-based algorithm can be utilized to accurately identify HIV-infected cohorts seen in the nationwide VA health care system.

Identifiants

pubmed: 31131549
doi: 10.1111/hiv.12757
pmc: PMC6687524
mid: NIHMS1025883
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

567-570

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States
Organisme : HSRD VA
ID : I50 HX001236
Pays : United States
Organisme : National Institute of Health
ID : CA206476-03
Pays : International
Organisme : VA Health Services Research Center for Innovations in Quality, Effectiveness and Safety
ID : CIN 13-413
Pays : International
Organisme : VA
ID : CX001430-02
Pays : United States
Organisme : CSRD VA
ID : I01 CX001430
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206476
Pays : United States

Informations de copyright

© 2019 British HIV Association.

Références

PLoS One. 2015 Dec 02;10(12):e0142966
pubmed: 26629701
PLoS One. 2015 Jun 17;10(6):e0129550
pubmed: 26083524
J Clin Epidemiol. 2001 Dec;54 Suppl 1:S12-5
pubmed: 11750204
Med Care. 2006 Aug;44(8 Suppl 2):S25-30
pubmed: 16849965
Lancet HIV. 2015 Aug;2(8):e335-43
pubmed: 26423376
Med Care. 2006 Aug;44(8 Suppl 2):S7-12
pubmed: 16849970

Auteurs

J R Kramer (JR)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.

C Hartman (C)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.

D L White (DL)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Center for Translational Research in Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, TX, USA.

K Royse (K)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

P Richardson (P)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

A P Thrift (AP)

Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.

S Raychaudhury (S)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.

R Desiderio (R)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.

D Sanchez (D)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.

E Y Chiao (EY)

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH